Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

Int J Nanomedicine. 2014 May 22;9:2539-55. doi: 10.2147/IJN.S47129. eCollection 2014.

Abstract

The growing research interest in nanomedicine for the treatment of cancer and inflammatory-related pathologies is yielding encouraging results. Unfortunately, enthusiasm is tempered by the limited specificity of the enhanced permeability and retention effect. Factors such as lack of cellular specificity, low vascular density, and early release of active agents prior to reaching their target contribute to the limitations of the enhanced permeability and retention effect. However, improved nanomedicine designs are creating opportunities to overcome these problems. In this review, we present examples of the advances made in this field and endeavor to highlight the potential of these emerging technologies to improve targeting of nanomedicine to specific pathological cells and tissues.

Keywords: cancer treatment; inflammation; nanomedicine; permeability and retention effect; tissue targeting.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / pharmacokinetics
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacokinetics
  • Biological Availability
  • Drug Compounding / methods
  • Drug Design
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / metabolism
  • Nanocapsules / chemistry*
  • Nanocapsules / therapeutic use*
  • Nanocapsules / ultrastructure
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Nanocapsules